Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection - 02/03/22
Doi : 10.1016/j.jinf.2021.12.013
Luana Coltella a, Stefania Ranno ⁎, a 
, Livia Piccioni a, Giulia Linardos a, Luna Colagrossi a, Marilena Agosta a, Cristina Russo a, Carlo Concato a, Andrea Campana b, Andrea Onetti Muda c, Alberto Villani b, Carlo Federico Perno a
, Livia Piccioni a, Giulia Linardos a, Luna Colagrossi a, Marilena Agosta a, Cristina Russo a, Carlo Concato a, Andrea Campana b, Andrea Onetti Muda c, Alberto Villani b, Carlo Federico Perno a a Department of Diagnostic and Laboratory Medicine, Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children Hospital IRCCS, Piazza Sant'Onofrio, Rome 400165, Italy
b Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio, Rome 400165, Italy
c Department of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio, Rome 400165, Italy
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Graphical abstract |
© 2021
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 3
P. 418-467 - mars 2022 Retour au numéro
Article précédent
- HIV-associated talaromycosis: Does timing of antiretroviral therapy matter?
- Yuanyuan Qin, Yihong Zhou, Songtao Liu, Yanqiu Lu, Min Liu, Jing Yuan, Jingmin Nie, Jing Ouyang, Hao Wu, Yingmei Qin, Zhongsheng Jiang, Guoqiang Zhou, Qun Tian, Ke Lan, Yang Zhou, Xinping Yang, Kaiyin He, Jun Liu, Vijay Harypursat, Yaokai Chen
- The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors
- Geng Qin, Jie Yang, Chuanqi Zhao, Jinsong Ren, Xiaogang Qu
Bienvenue sur EM-consulte, la référence des professionnels de santé.